Pharmaco - Articles
08-Oct-2019
A list of the TOP Pharma Companies who are hiring this month (September)
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products.
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products. Before any biopharmaceutical product goes in to market, it has to get marketing authorization from the relevant health authorities. Market authorization is issued on the basis of an assessment of submitted information that describes the quality, safety and efficacy of the product for a specified indication. Applicants and manufacturers often implement changes in the product, production process, quality controls, equipment, facilities, responsible personnel, or labeling estab…
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products. Before any biopharmaceutical product goes in to market, it has to get marketing authorization from the relevant health authorities. Market authorization is issued on the basis of an assessment of submitted information that describes the quality, safety and efficacy of the product for a specified indication. Applicants and manufacturers often implement changes in the product, production process, quality controls, equipment, facilities, responsible personnel, or labeling estab…
Herald Meetings brings forth International Conference on Nanotechnology and Nanomaterials the one which is going to takes place at most historic place in Europe Rome, Italy on March 02-03, 2020 brings together leading experts, scientists, researchers, engineers and policymakers in the field of Nanotechnology to Exchange information on the latest innovation and progress. Where you can Connect| Learn| Collaborate
Conference Brochure | Submit Abstract | Scientific Sessions Herald Meetings takes pleasure in inviting the scientific community across the globe to attend the International Conference on Nanotechnology and Nanomaterials during March 02-03, 2020 at Rome, Italy around the theme "Inquisition of Nanotechnology for better prospective" Why to Attend?? Nanotechnology 2020 Conf…
Conference Brochure | Submit Abstract | Scientific Sessions Herald Meetings takes pleasure in inviting the scientific community across the globe to attend the International Conference on Nanotechnology and Nanomaterials during March 02-03, 2020 at Rome, Italy around the theme "Inquisition of Nanotechnology for better prospective" Why to Attend?? Nanotechnology 2020 Conf…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it?
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventua…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventua…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
22-Jul-2019
Regulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future employers and get essential advice from some of the most respected and influential leaders in the field of regulatory affairs
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency.
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital trans…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital trans…
12-Apr-2019
PharmiWeb.jobs a new jobs board
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble To find our Jobs and other similar jobs please check Jooble. Jooble is a job search engine operated in 70 countries worldwide.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs, whilst extending the scope of its research and improving patient and clinical experiences.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs,…
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs,…
14-Jan-2019
Learning the microbead lesson
A UK-wide prohibition on the use of plastic microbeads came into effect in 2018, but what fundamental lessons can we learn from this high profile case? Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd. explains all. Figures from The Department for the Environment, Food and Rural Affairs (DEFRA) suggest that an estimated 680 tonnes of microbeads are used in cosmetic products every year. These tiny pieces of plastic, used for exfoliation in rinse-off products such as toothpastes, face scrubs and shower gels, inevitably end up contaminating the environment. With particle sizes varying from 10 micrometers up to 1 millimetre, microbeads are the same size as much of the organic…
A UK-wide prohibition on the use of plastic microbeads came into effect in 2018, but what fundamental lessons can we learn from this high profile case? Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd. explains all. Figures from The Department for the Environment, Food and Rural Affairs (DEFRA) suggest that an estimated 680 tonnes of microbeads are used in cosmetic products every year. These tiny pieces of plastic, used for exfoliation in rinse-off products such as toothpastes, face scrubs and shower gels, inevitably end up contaminating the environment. With particle sizes varying from 10 micrometers up to 1 millimetre, microbeads are the same size as much of the organic…
Preclinical IPOs: Is the window starting to close?
A record-breaking year is on the cards, as biotechnology companies continue the trend of pre-clinical initial public offerings (IPOs). As of July, six young firms had raised almost $800million through their IPOs, despite none having permission from regulators to start clinical trials in humans.[1] These companies are now generating significant returns. For example, the most recent preclinical IPO by Gritstone Oncology Inc was initially valued at $100 million, and as of 12 December 2018 has a market value of $731 million.1 Pre-clinical valuations Traditionally, there are two good times for biotech companies to go public: right after proof or concept in humans or upon the publication of promising, pivotal data. But these pre-clinical…
A record-breaking year is on the cards, as biotechnology companies continue the trend of pre-clinical initial public offerings (IPOs). As of July, six young firms had raised almost $800million through their IPOs, despite none having permission from regulators to start clinical trials in humans.[1] These companies are now generating significant returns. For example, the most recent preclinical IPO by Gritstone Oncology Inc was initially valued at $100 million, and as of 12 December 2018 has a market value of $731 million.1 Pre-clinical valuations Traditionally, there are two good times for biotech companies to go public: right after proof or concept in humans or upon the publication of promising, pivotal data. But these pre-clinical…
07-Feb-2019
~ Unpacking the potential of smart packaging ~
One of the biggest challenges for manufacturers of consumable goods is how to extend product shelf life while ensuring safety. Over the past hundred years, the food and beverage industry has invested billions of pounds in researching suitable packaging, but what can the pharmaceutical industry learn from this?
Here, Dale Pittock, sales director of pharmacy consumables provider Valley Northern, explores the latest developments in the smart packaging market. Imagine if a packet of antibiotics could tell a patient whether it had been opened and which pill had been taken and at what time. Then, imagine if things could be taken a step further and the medication could alert patients when it was time to take the next one, then feed this informati…
Here, Dale Pittock, sales director of pharmacy consumables provider Valley Northern, explores the latest developments in the smart packaging market. Imagine if a packet of antibiotics could tell a patient whether it had been opened and which pill had been taken and at what time. Then, imagine if things could be taken a step further and the medication could alert patients when it was time to take the next one, then feed this informati…
30-Nov-2018
~ Pharmacy and healthcare supplier releases advisory whitepaper ~
Leading pharmacy and healthcare consumables supplier, Valley Northern, has released its latest whitepaper, exploring the increasing issue of patient non-adherence. The whitepaper, which can be downloaded directly from the Valley Northern website, looks at why non-adherence is an issue and how those across the healthcare industry can help to tackle it. Download the whitepaper here: Valley Northern Downloads.Across the United Kingdom, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of a recent industry report admitted to not taking their medication as prescribed. The issue of patient non-adherence is a big issue, particularly when patients try to take thei…
Leading pharmacy and healthcare consumables supplier, Valley Northern, has released its latest whitepaper, exploring the increasing issue of patient non-adherence. The whitepaper, which can be downloaded directly from the Valley Northern website, looks at why non-adherence is an issue and how those across the healthcare industry can help to tackle it. Download the whitepaper here: Valley Northern Downloads.Across the United Kingdom, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of a recent industry report admitted to not taking their medication as prescribed. The issue of patient non-adherence is a big issue, particularly when patients try to take thei…
26-Nov-2018
How technology at an operational level is the driving force behind innovative pharmaceutical businesses
The global pharmaceutical industry is often held up as an example of a sector that exists on the cutting edge of what is possible. But that doesn’t mean that it can avoid its own tech disruption.Digitalisation - the process of moving to digital business processes and away from legacy and paper-based ones - is changing the pharmaceutical industry just as it is changing many others. One seemingly simple, yet business-critical change will be in how companies collect, share and analyse data, with the result that digitalisation will have a radical effect on how products and processes are audited.When a consumer buys aspirin, paracetamol or any of the thousands of over-the-counter medic…
The global pharmaceutical industry is often held up as an example of a sector that exists on the cutting edge of what is possible. But that doesn’t mean that it can avoid its own tech disruption.Digitalisation - the process of moving to digital business processes and away from legacy and paper-based ones - is changing the pharmaceutical industry just as it is changing many others. One seemingly simple, yet business-critical change will be in how companies collect, share and analyse data, with the result that digitalisation will have a radical effect on how products and processes are audited.When a consumer buys aspirin, paracetamol or any of the thousands of over-the-counter medic…
Neo4j’s Emil Eifrem takes a look at how life science researchers can use graph databases to get granular insight from big data and make real advances in research
Neo4j’s Emil Eifrem takes a look at how life science researchers can use graph databases to get granular insight from big data and make real advances in researchBig data, defined as large complex data sets, has the potential to throw light onto every link in the life sciences value chain, which is why data mining has become so important to researchers – but having the right technology is key to its success.Traditional database tools, namely SQL and relational database technology, find the volume as well as the unstructured nature of these complex datasets extremely difficult to work with. Why? Because they model the world as a set…
Neo4j’s Emil Eifrem takes a look at how life science researchers can use graph databases to get granular insight from big data and make real advances in researchBig data, defined as large complex data sets, has the potential to throw light onto every link in the life sciences value chain, which is why data mining has become so important to researchers – but having the right technology is key to its success.Traditional database tools, namely SQL and relational database technology, find the volume as well as the unstructured nature of these complex datasets extremely difficult to work with. Why? Because they model the world as a set…
How Finance 4.0 can deliver cutting-edge technology to the pharmaceutical industry
The pharmaceutical industry is increasingly making use of modern digitalised technology to automate specific processes in drug development, testing and manufacturing, one UK based company predicts they will be able to commercialise printed tablets (using 3D printing) within the next 5 to 10 years.[1] New techniques such as personalised medicine, where the care and treatment of patients moves away from a ‘one size fits all’ approach and instead uses diagnostics, genomics and data analytics to identify the underlying cause of disease, have encouraged a wave of activity in the biotech sector, with several companies now offering a range of complex gene editing services.[2]Similarly, Artificial Intelligence (AI) i…
The pharmaceutical industry is increasingly making use of modern digitalised technology to automate specific processes in drug development, testing and manufacturing, one UK based company predicts they will be able to commercialise printed tablets (using 3D printing) within the next 5 to 10 years.[1] New techniques such as personalised medicine, where the care and treatment of patients moves away from a ‘one size fits all’ approach and instead uses diagnostics, genomics and data analytics to identify the underlying cause of disease, have encouraged a wave of activity in the biotech sector, with several companies now offering a range of complex gene editing services.[2]Similarly, Artificial Intelligence (AI) i…
Managing translations for submissions in regulatory affairs – what is best practice?
Managing translations for submissions in regulatory affairs – what is best practice? Few heads of regulatory affairs would dispute the complexity of compliance and regulation in the life sciences industry. Changing regulations puts greater pressure on regulatory professionals and makes the job of translating content for submissions ever more difficult, while the pressure to decrease time-to-market for life-saving new drug therapies grows all the time. Regulations change so frequently in countries all the time, that there is an almost constant re-evaluation as to what is needed to be included in dossiers and what parts of the dossier require translation. Given such challenges, whether handling translations f…
Managing translations for submissions in regulatory affairs – what is best practice? Few heads of regulatory affairs would dispute the complexity of compliance and regulation in the life sciences industry. Changing regulations puts greater pressure on regulatory professionals and makes the job of translating content for submissions ever more difficult, while the pressure to decrease time-to-market for life-saving new drug therapies grows all the time. Regulations change so frequently in countries all the time, that there is an almost constant re-evaluation as to what is needed to be included in dossiers and what parts of the dossier require translation. Given such challenges, whether handling translations f…
Maintaining the highest recruitment standards puts pharma companies at ease
With the pharmaceutical industry experiencing unprecedented talent shortages, the importance of finding a trusted partner to supply talent that can deliver to the highest professional standard has never been greater, which is why SEC has announced their delight at once again obtaining both bronze and silver Workforce Quality Accreditation from IAOCR.The accreditation – awarded to organisations that demonstrate a commitment to professionalism and competence in their own workforce – included a full analysis of SEC’s working practices and following the re-accreditation, Global Head of Workforce Strategy and Innovation Angela O’Connell, said “From the initiation of the Workforce Quality Accreditation, SEC Recruitment ha…
With the pharmaceutical industry experiencing unprecedented talent shortages, the importance of finding a trusted partner to supply talent that can deliver to the highest professional standard has never been greater, which is why SEC has announced their delight at once again obtaining both bronze and silver Workforce Quality Accreditation from IAOCR.The accreditation – awarded to organisations that demonstrate a commitment to professionalism and competence in their own workforce – included a full analysis of SEC’s working practices and following the re-accreditation, Global Head of Workforce Strategy and Innovation Angela O’Connell, said “From the initiation of the Workforce Quality Accreditation, SEC Recruitment ha…
More focus on SRG Clinical – this time in Europe!
More focus on SRG Clinical – this time in Europe!Since 1990, SRG’s Clinical division has been committed to providing outstanding temporary, contract and permanent resourcing services to its clients and career opportunities in all areas of clinical research and drug development across the UK and Europe. Following the exciting progress of SRG’s Clinical team over the last year, we have now taken the next step in pursuing our growth plans by appointing Julian Stec to fly the SRG flag in Poland and beyond. This appointment will expand our Clinical Business Development function and solidify our presence in Europe.Based in Warsaw and focusing on expanding our presence with existing and new clients, Julian comes with the great advantage of expert…
More focus on SRG Clinical – this time in Europe!Since 1990, SRG’s Clinical division has been committed to providing outstanding temporary, contract and permanent resourcing services to its clients and career opportunities in all areas of clinical research and drug development across the UK and Europe. Following the exciting progress of SRG’s Clinical team over the last year, we have now taken the next step in pursuing our growth plans by appointing Julian Stec to fly the SRG flag in Poland and beyond. This appointment will expand our Clinical Business Development function and solidify our presence in Europe.Based in Warsaw and focusing on expanding our presence with existing and new clients, Julian comes with the great advantage of expert…
04-Oct-2018
Clinical Research – Quo Vadis?
Clinical Research – Quo Vadis?In recent times we began observing a significant acceleration of technology development which aims at improving the quality and speed of clinical trials as well as lowering the costs of it.It would seem that moving from simple paper digitalization to IoE (Internet of Everything) and Big Data will reduce the demand for qualified on-site CRA workforce. But will it? And would it completely wipe out the needs? There are ones who prophesies this is inevitable, but personally, I doubt that. Why, you may ask? GCP regulation is very clear about it - ICH GCP 5.18.1 (a) states: “The purpose of clinical trial monitoring is to verify that the rights and well-being of human subjects are protected.” Although today's CRA skillset is far…
Clinical Research – Quo Vadis?In recent times we began observing a significant acceleration of technology development which aims at improving the quality and speed of clinical trials as well as lowering the costs of it.It would seem that moving from simple paper digitalization to IoE (Internet of Everything) and Big Data will reduce the demand for qualified on-site CRA workforce. But will it? And would it completely wipe out the needs? There are ones who prophesies this is inevitable, but personally, I doubt that. Why, you may ask? GCP regulation is very clear about it - ICH GCP 5.18.1 (a) states: “The purpose of clinical trial monitoring is to verify that the rights and well-being of human subjects are protected.” Although today's CRA skillset is far…
